You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

Viatris Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for VIATRIS, and what generic and branded alternatives to VIATRIS drugs are available?

VIATRIS has seventeen approved drugs.



Summary for Viatris
US Patents:0
Tradenames:12
Ingredients:10
NDAs:17

Drugs and US Patents for Viatris

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Viatris REVATIO sildenafil citrate TABLET;ORAL 021845-001 Jun 3, 2005 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial
Viatris ZOLOFT sertraline hydrochloride CONCENTRATE;ORAL 020990-001 Dec 7, 1999 AA RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial
Viatris NEURONTIN gabapentin CAPSULE;ORAL 020235-003 Dec 30, 1993 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial
Viatris CARDURA doxazosin mesylate TABLET;ORAL 019668-003 Nov 2, 1990 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial
Viatris NEURONTIN gabapentin CAPSULE;ORAL 020235-002 Dec 30, 1993 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial
Viatris REVATIO sildenafil citrate FOR SUSPENSION;ORAL 203109-001 Aug 30, 2012 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial
Viatris NORVASC amlodipine besylate TABLET;ORAL 019787-001 Jul 31, 1992 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Viatris

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Viatris ZOLOFT sertraline hydrochloride CONCENTRATE;ORAL 020990-001 Dec 7, 1999 5,744,501 ⤷  Try a Trial
Viatris GEODON ziprasidone mesylate POWDER;INTRAMUSCULAR 020919-001 Jun 21, 2002 6,232,304 ⤷  Try a Trial
Viatris GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-002 Feb 5, 2001 6,245,766 ⤷  Try a Trial
Viatris NEURONTIN gabapentin CAPSULE;ORAL 020235-002 Dec 30, 1993 5,084,479*PED ⤷  Try a Trial
Viatris ZOLOFT sertraline hydrochloride CONCENTRATE;ORAL 020990-001 Dec 7, 1999 6,727,283*PED ⤷  Try a Trial
Viatris ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-003 Dec 30, 1991 5,789,449 ⤷  Try a Trial
Viatris NEURONTIN gabapentin TABLET;ORAL 020882-002 Oct 9, 1998 5,084,479*PED ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for VIATRIS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 150 mg and 200 mg ➤ Subscribe 2005-11-09
➤ Subscribe Tablets 100 mg ➤ Subscribe 2004-10-25
➤ Subscribe Sublingual Tablets 0.6 mg ➤ Subscribe 2011-12-29
➤ Subscribe Capsules 20 mg, 40 mg, 60 mg and 80 mg ➤ Subscribe 2005-02-07
➤ Subscribe Tablets 25 mg and 50 mg ➤ Subscribe 2004-11-19
➤ Subscribe Sublingual Tablets 0.3 mg, 0.4 mg and 0.6 mg ➤ Subscribe 2005-10-19
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.